You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Sale Disclosure
Innovative Cellular Therapeutics Holdings Ltd · SEC Form 4 · Filed Jul 20, 2026
Sale
Calculated transaction value
$137
Innovative Cellular Therapeutics Holdings Ltd 10% owner
LYEL
Lyell Immunopharma
LYEL
Transaction date
Jul 17, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 3 days later
LYEL daily price context
Close on/before transaction
$13.32
Jul 17, 2026
First close after public filing
$12.92
Jul 20, 2026
30-day return after filing
+21.98%
Through Aug 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10 shares @ $13.7
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-028955
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$137
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Sale | Jul 17, 2026 | $137 |